Drug Profile
Calcitriol topical - Berg Pharma
Alternative Names: 31543; API-31543; BPM-31543Latest Information Update: 24 Feb 2023
Price :
$50
*
At a glance
- Originator Berg Pharma
- Class Antipsoriatics; Chemoprotectants; Dihydroxycholecalciferols; Osteoporosis therapies; Small molecules; Vitamin D analogues
- Mechanism of Action Gene expression modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Alopecia
- Discontinued Myelosuppression
Most Recent Events
- 28 Jan 2022 No recent reports of development identified for phase-I development in Alopecia(Chemotherapy-induced) in USA (Topical)
- 06 Dec 2018 Calcitrol is still in phase I clinical trials in Alopecia (Chemotherapy-induced) in USA (Topical) (Berg Pharma pipeline, December 2018)
- 19 Oct 2018 Final adverse events data from a phase I trial in chemotherapy-induced Alopecia presented at the 43rd European Society for Medical Oncology Congress (ESMO-2018)